Patents by Inventor Kuniyasu NIIZUMA

Kuniyasu NIIZUMA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11850232
    Abstract: A drug used for treating or preventing cerebral hemorrhage, the drug including, as an active ingredient, a compound represented by the following Formula (I) or a pharmaceutically acceptable salt, ester, or solvate thereof:
    Type: Grant
    Filed: November 30, 2020
    Date of Patent: December 26, 2023
    Assignee: BIOGEN MA INC.
    Inventors: Teiji Tominaga, Kuniyasu Niizuma
  • Publication number: 20230046302
    Abstract: A blood flow field estimation apparatus is provided, including an estimation unit that uses a learned model obtained in advance by performing machine learning to learn a relationship between organ tissue three-dimensional structure data including image data of a plurality of organ cross-sectional images serving as cross-sectional images of an organ and having each pixel provided with two or more bit depths and image position information serving as information indicating a position of an image reflected on each of the organ cross-sectional images in the organ, and a blood flow field in the organ, and estimates the blood flow field in the organ of an estimation target, based on the organ tissue three-dimensional structure data of the organ of the estimation target, and an output unit that outputs an estimation result of the estimation unit.
    Type: Application
    Filed: February 22, 2021
    Publication date: February 16, 2023
    Inventors: Hitomi ANZAI, Kazuhiro WATANABE, Gaoyang LI, Makoto OHTA, Teiji TOMINAGA, Kuniyasu NIIZUMA, Shinichiro SUGIYAMA
  • Publication number: 20220395536
    Abstract: An object is to provide a cell product for treating and/or preventing vascular dementia. The present invention provides a cell product for treating or preventing vascular dementia, containing a SSEA-3-positive pluripotent stem cell (Muse cell) derived from a mesenchymal tissue in a living body or a SSEA-3-positive pluripotent stem cell derived from a cultured mesenchymal cell.
    Type: Application
    Filed: August 7, 2020
    Publication date: December 15, 2022
    Applicants: TOHOKU UNIVERSITY, LIFE SCIENCE INSTITUTE, INC.
    Inventors: Kuniyasu NIIZUMA, Teiji TOMINAGA
  • Publication number: 20210322381
    Abstract: A drug used for treating or preventing cerebral hemorrhage, the drug including, as an active ingredient, a compound represented by the following Formula (I) or a pharmaceutically acceptable salt, ester, or solvate thereof:
    Type: Application
    Filed: November 30, 2020
    Publication date: October 21, 2021
    Inventors: Teiji TOMINAGA, Kuniyasu NIIZUMA